Genocea

GNCA NASDAQ
5.38
+0.11
+2.09%
盘后: 5.38 0 0.00% 17:52 06/17 EDT
开盘
5.25
昨收
5.27
最高
5.48
最低
5.14
成交量
15.13万
成交均量(3M)
83.22万
52周最高
11.28
52周最低
2.240
换手率
1.08%
市值
7,558.95万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Genocea GNCA股票价格,Genocea股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Genocea Biosciences, Inc., is harnessing the power of T cell immunity to develop vaccines and immunotherapies company. The Company uses its discovery platform, AnTigen Lead Acquisition System (ATLAS), to design vaccines and immunotherapies that act, in part, through T cell (or cellular) immune responses. The Company has one product candidate in Phase III clinical development, GEN-003, an immunotherapy for the treatment of genital herpes. It also has a pre-clinical immuno-oncology program focused on personalized cancer vaccines (GEN-009). The GEN-009 program leverages ATLAS to identify patient neoantigens, or newly formed antigens unique to each patient, that are associated with that individual's tumor.
展开 >

最近浏览

名称
价格
涨跌幅